CVIR Endovascular最新文献

筛选
英文 中文
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study. 股骨干病变的重复药物涂层球囊血管成形术:一项回顾性观察研究的 12 个月结果。
IF 1.2
CVIR Endovascular Pub Date : 2024-02-29 DOI: 10.1186/s42155-024-00434-w
Takuya Haraguchi, Masanaga Tsujimoto, Yoshifumi Kashima, Katsuhiko Sato, Tsutomu Fujita
{"title":"Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study.","authors":"Takuya Haraguchi, Masanaga Tsujimoto, Yoshifumi Kashima, Katsuhiko Sato, Tsutomu Fujita","doi":"10.1186/s42155-024-00434-w","DOIUrl":"10.1186/s42155-024-00434-w","url":null,"abstract":"<p><strong>Background: </strong>The clinical implications of restenosis after drug-coated balloon (DCB) treatment remain unclear. We compared the clinical outcomes between DCB angioplasty for restenosis and de novo femoropopliteal artery lesions. This single-center retrospective study included 571 patients (737 limbs) who underwent either repeat (54 patients, 64 limbs) or de novo DCB (517 patients, 673 limbs) without bailout stenting. After propensity score matching, 49 matched pairs were analyzed. The primary endpoint was the 1-year primary patency, with secondary endpoints including the freedom from target lesion revascularization (TLR), major adverse limb events (MALE), and early restenosis. Predictors of restenosis were identified using multivariable Cox regression analysis.</p><p><strong>Results: </strong>The repeat-DCB group displayed significantly lower rates of 1-year primary patency and freedom from TLR compared to those of the de novo-DCB group (50.1% vs. 77.4%, p = 0.029 and 54.9% vs. 83.6%, p = 0.0.44, respectively). No significant differences were observed in early restenosis or MALE (10.7% vs. 5.9%, p = 0.455 and 48.3% vs. 73.4%, p = 0.055, respectively). Restenosis after DCB angioplasty was associated with repeat DCB (hazard ratio [HR], 5.13; 95% confidence interval [CI], 1.43-18.4; p = 0.012) and small vessel size of < 4.5 mm (HR, 6.25; 95% CI, 1.17-33.4; p = 0.032). Furthermore, restenosis after repeat DCB angioplasty was associated with the Peripheral Artery Calcification Scoring System (PACSS) grade 4 (HR, 4.20; 95% CI, 1.08-16.3; p = 0.038), small vessel size of < 4.5 mm (HR, 9.44; 95% CI, 1.21-73.7; p = 0.032), and intravascular ultrasound (IVUS) use (HR, 0.05; 95% CI, 0.01-0.44; p = 0.007).</p><p><strong>Conclusions: </strong>The 1-year primary patency rate following repeat DCB angioplasty for femoropopliteal lesions was notably lower than that of DCB treatment for de novo lesions. Repeat DCB strategy was associated with an increased risk of patency loss. Regarding repeat restenosis after DCB treatments, PACSS grade 4 calcification and small vessel diameter of < 4.5 mm were associated with an increased risk of restenosis, whereas IVUS use correlated with a decreased risk of restenosis.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"24"},"PeriodicalIF":1.2,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10904691/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Viabahn stent graft for arterial injury management: safety, technical success, and long-term outcome. 用于动脉损伤治疗的 Viabahn 支架移植:安全性、技术成功率和长期疗效。
IF 1.2
CVIR Endovascular Pub Date : 2024-02-28 DOI: 10.1186/s42155-024-00435-9
Jan M Brendel, Tobias Mangold, Mario Lescan, Jörg Schmehl, Patrick Ghibes, Antonia Grimm, Simon Greulich, Patrick Krumm, Christoph Artzner, Gerd Grözinger, Arne Estler
{"title":"Viabahn stent graft for arterial injury management: safety, technical success, and long-term outcome.","authors":"Jan M Brendel, Tobias Mangold, Mario Lescan, Jörg Schmehl, Patrick Ghibes, Antonia Grimm, Simon Greulich, Patrick Krumm, Christoph Artzner, Gerd Grözinger, Arne Estler","doi":"10.1186/s42155-024-00435-9","DOIUrl":"10.1186/s42155-024-00435-9","url":null,"abstract":"<p><strong>Background: </strong>The Viabahn stent graft has emerged as an integral tool for managing vascular diseases, but there is limited long-term data on its performance in emergency endovascular treatment. This study aimed to assess safety, technical success, and long-term efficacy of the Viabahn stent graft in emergency treatment of arterial injury.</p><p><strong>Methods: </strong>We conducted a retrospective single tertiary centre analysis of patients who underwent Viabahn emergency arterial injury treatment between 2015 and 2020. Indication, intraoperative complications, technical and clinical success, and major adverse events at 30 days were evaluated. Secondary efficacy endpoints were the primary and secondary patency rates assessed by Kaplan-Meier analysis.</p><p><strong>Results: </strong>Forty patients (71 ± 13 years, 19 women) were analyzed. Indications for Viabahn emergency treatment were extravasation (65.0%), arterio-venous fistula (22.5%), pseudoaneurysm (10.0%), and arterio-ureteral fistula (2.5%). No intraoperative adverse events occurred, technical and clinical success rates were 100%. One acute stent graft occlusion occurred in the popliteal artery on day 9, resulting in a 30-day device-related major-adverse-event rate of 2.5%. Median follow-up was 402 days [IQR, 43-1093]. Primary patency rate was 97% (95% CI: 94-100) in year 1, and 92% (95% CI: 86-98) from years 2 to 6. One stent graft occlusion occurred in the external iliac artery at 18 months; successful revascularization resulted in secondary patency rates of 97% (95% CI: 94-100) from years 1 to 6.</p><p><strong>Conclusion: </strong>Using Viabahn stent graft in emergency arterial injury treatment had 100% technical and clinical success rates, a low 30-day major-adverse-event rate of 2.5%, and excellent long-term patency rates.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"23"},"PeriodicalIF":1.2,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139984520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A technique to retrieve an internalised embedded central venous catheter 取出内嵌式中心静脉导管的技术
IF 1.2
CVIR Endovascular Pub Date : 2024-02-26 DOI: 10.1186/s42155-024-00436-8
John Finnegan, Pradeep Govender
{"title":"A technique to retrieve an internalised embedded central venous catheter","authors":"John Finnegan, Pradeep Govender","doi":"10.1186/s42155-024-00436-8","DOIUrl":"https://doi.org/10.1186/s42155-024-00436-8","url":null,"abstract":"Central venous catheters may become embedded due to the formation of adhesions between the indwelling catheter and the vein wall. A 49-year-old patient with bacteraemia was referred for retrieval of an embedded internalised central venous dialysis catheter. Recently the catheter had been surgically ligated at the venotomy site internalising the intravascular catheter component, which precluded antegrade ballooning through the catheter hub. Seldinger technique was used to access the catheter lumen within the left internal jugular vein and through and through access was established across the catheter. Retrograde endoluminal balloon dilation was performed to disrupt adhesions and free the catheter. The catheter was snared over the wire and removed from the right femoral vein. This case report outlines an effective, minimally invasive retrieval method in a rare case of an embedded internalised central venous catheter. ","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"30 1","pages":""},"PeriodicalIF":1.2,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139969815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reverse sheathing technique for iliocaval thrombectomy in the setting of IVC filters 在使用 IVC 过滤器的情况下采用反向套管技术进行髂腹腔血栓切除术
IF 1.2
CVIR Endovascular Pub Date : 2024-02-22 DOI: 10.1186/s42155-024-00437-7
Joshua Cornman-Homonoff, Angelo G. Marino, Hamid Mojibian
{"title":"Reverse sheathing technique for iliocaval thrombectomy in the setting of IVC filters","authors":"Joshua Cornman-Homonoff, Angelo G. Marino, Hamid Mojibian","doi":"10.1186/s42155-024-00437-7","DOIUrl":"https://doi.org/10.1186/s42155-024-00437-7","url":null,"abstract":"The Inari ClotTriever system (Inari Medical, Irvine, California) is safe and effective for the treatment of DVT. However, because it consists of a 31 cm coring device and collection bag that must be extended for use, application may be precluded by available intravascular “running room”, such as in the presence of an IVC filter. Here we present a technique for bypassing IVC filters via retrograde deployment of the ClotTriever within a sheath, as illustrated in three cases. This technique extends the applicability of the ClotTriever to locations in which its length would otherwise preclude use.","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"27 1","pages":""},"PeriodicalIF":1.2,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139918258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound (US)-guided percutaneous thrombin injection for stoma-site bleeding after PEG tube insertion: a case series and review of the literature. 超声(US)引导下经皮凝血酶注射治疗插入 PEG 管后造口部位出血:系列病例和文献综述。
IF 1.2
CVIR Endovascular Pub Date : 2024-02-20 DOI: 10.1186/s42155-024-00432-y
Aws Alfahad, Rawan Alhalabi
{"title":"Ultrasound (US)-guided percutaneous thrombin injection for stoma-site bleeding after PEG tube insertion: a case series and review of the literature.","authors":"Aws Alfahad, Rawan Alhalabi","doi":"10.1186/s42155-024-00432-y","DOIUrl":"10.1186/s42155-024-00432-y","url":null,"abstract":"<p><strong>Background: </strong>Post-gastrostomy bleeding sequelae are acknowledged, with reported approaches focusing on conservative measures or surgical repair. Nonetheless, Percutaneous Thrombin Injections (PTI) role in PEG-site-related bleeding remains underexplored. PTI under ultrasound guidance is an advocated management strategy for stoma-site bleeding following gastrostomy in high-risk patients, particularly those on direct oral anticoagulants.</p><p><strong>Case presentation: </strong>This study presents three cases with multiple comorbidities who underwent PTI. Resulting in immediate resolution of bleeding, no systemiclocal effect, and no reported complications or rebleeding after a 3-6-month follow-up.</p><p><strong>Conclusion: </strong>The findings highlight the safety, direct complete resolution, and absence of sequelae associated with PTI, suggesting its potential as a promising technique in managing PEG stoma-related bleeding.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"20"},"PeriodicalIF":1.2,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879047/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139906876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous balloon-assisted ultrasound-guided direct thrombin embolization of superficial femoral artery pseudoaneurysm: a case series and literature review. 经皮球囊辅助超声引导直接凝血酶栓塞股浅动脉假性动脉瘤:病例系列和文献综述。
IF 1.2
CVIR Endovascular Pub Date : 2024-02-16 DOI: 10.1186/s42155-024-00428-8
Antonio Bruno, Francesco Vendetti, Nicolas Papalexis, Mattia Russo, Dimitris Papadopoulos, Cristina Mosconi
{"title":"Percutaneous balloon-assisted ultrasound-guided direct thrombin embolization of superficial femoral artery pseudoaneurysm: a case series and literature review.","authors":"Antonio Bruno, Francesco Vendetti, Nicolas Papalexis, Mattia Russo, Dimitris Papadopoulos, Cristina Mosconi","doi":"10.1186/s42155-024-00428-8","DOIUrl":"10.1186/s42155-024-00428-8","url":null,"abstract":"<p><strong>Background: </strong>Superficial femoral artery (SFA) pseudoaneurysms, a rare but potentially life-threatening complication, that can arise after vascular interventions or trauma. This case series explores the efficacy and safety of a minimally invasive treatment modality, percutaneous ultrasound-guided thrombin injection (PUGTI) combined with balloon occlusion, in three patients with SFA pseudoaneurysms.</p><p><strong>Case presentation: </strong>Three patients (age: 71-82 years; 3 female) with SFA pseudoaneurysms underwent PUGTI with balloon occlusion. The procedure involved direct thrombin injection under ultrasound guidance while occluding the parent artery using a balloon catheter. Follow-up was conducted at 1 week and 1 month post-procedure to assess technical success, complications, and recurrence.</p><p><strong>Conclusion: </strong>PUGTI combined with balloon occlusion appears to be a safe and effective treatment for SFA pseudoaneurysms, particularly for larger pseudoaneurysms. The procedure is associated with a high technical success rate. Balloon occlusion may offer a safer alternative to direct thrombin injection without occlusion, as it potentially minimizes the risk of complications such as distal thromboembolism.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"19"},"PeriodicalIF":1.2,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10873257/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139742682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of novel radiation protection devices during radiologically guided interventions. 评估放射引导介入过程中的新型辐射防护装置。
IF 1.2
CVIR Endovascular Pub Date : 2024-02-14 DOI: 10.1186/s42155-024-00430-0
Maria E V Larsson, Pernilla I Jonasson, Petra S Apell, Peter P Kearney, Charlotta J Lundh
{"title":"Evaluation of novel radiation protection devices during radiologically guided interventions.","authors":"Maria E V Larsson, Pernilla I Jonasson, Petra S Apell, Peter P Kearney, Charlotta J Lundh","doi":"10.1186/s42155-024-00430-0","DOIUrl":"10.1186/s42155-024-00430-0","url":null,"abstract":"<p><strong>Background: </strong>In radiologically guided interventions, medical practitioners are subjected to radiation exposure, which may lead to radiation-induced diseases. In this study, novel radiation shields for the head and neck were evaluated for their potential to reduce radiation exposure.</p><p><strong>Method: </strong>An anthropomorphic phantom was exposed on its left side to scattered radiation from beneath to simulate the exposure of an operator in a x-ray operating room. Thermoluminescent dosimeters (TLDs) were positioned at different depths in five slices in the phantom, measuring personal dose equivalent. Two different set up situations were evaluated: a head protector designed to reduce radiation in the upper section of the head; and a novel thyroid protector prototype extended in the front and on both sides, designed to reduce radiation in the lower and middle sections of the head. A standard thyroid collar prototype and a ceiling mounted lead glass shield were used as comparisons. Furthermore, the head protector was evaluated in a clinical study in which TLDs were positioned to measure scattered radiation exposure to the heads of operators during endovascular interventions.</p><p><strong>Results: </strong>The extended thyroid protector reduced the scattered radiation in the throat, chin, and ear slices. Some shielding effect was seen in the brain and skull slices. The head protector showed a shielding effect in the skull slice up to two cm depth where it covered the phantom head. As expected, the ceiling mounted lead glass shield reduced the scattered radiation in all measuring points.</p><p><strong>Conclusions: </strong>A ceiling mounted lead glass shield is an effective radiation protection for the head, but in clinical practice, optimal positioning of a ceiling mounted lead shield may not always be possible, particularly during complex cases when radiation protection may be most relevant. Added protection using these novel guards may compliment the shielding effect of the ceiling mounted lead shield. The head protector stand-alone did not provide sufficient protection of the head. The extended thyroid protector stand-alone provided sufficient protection in the lower and middle sections of the head and neck.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"18"},"PeriodicalIF":1.2,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10866844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139730931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary and secondary postpartum haemorrhage: a review for a rationale endovascular approach. 原发性和继发性产后出血:对合理的血管内治疗方法的回顾。
IF 1.2
CVIR Endovascular Pub Date : 2024-02-13 DOI: 10.1186/s42155-024-00429-7
Alberto Alonso-Burgos, Ignacio Díaz-Lorenzo, Laura Muñoz-Saá, Guillermo Gallardo, Teresa Castellanos, Regina Cardenas, Luis Chiva de Agustín
{"title":"Primary and secondary postpartum haemorrhage: a review for a rationale endovascular approach.","authors":"Alberto Alonso-Burgos, Ignacio Díaz-Lorenzo, Laura Muñoz-Saá, Guillermo Gallardo, Teresa Castellanos, Regina Cardenas, Luis Chiva de Agustín","doi":"10.1186/s42155-024-00429-7","DOIUrl":"10.1186/s42155-024-00429-7","url":null,"abstract":"<p><p>Postpartum haemorrhage (PPH) is a significant cause of maternal mortality globally, necessitating prompt and efficient management. This review provides a comprehensive exploration of endovascular treatment dimensions for both primary and secondary PPH, with a focus on uterine atony, trauma, placenta accreta spectrum (PAS), and retained products of conception (RPOC). Primary PPH, occurring within 24 h, often results from uterine atony in 70% of causes, but also from trauma, or PAS. Uterine atony involves inadequate myometrial contraction, addressed through uterine massage, oxytocin, and, if needed, mechanical modalities like balloon tamponade. Trauma-related PPH may stem from perineal injuries or pseudoaneurysm rupture, while PAS involves abnormal placental adherence. PAS demands early detection due to associated life-threatening bleeding during delivery. Secondary PPH, occurring within 24 h to 6 weeks postpartum, frequently arises from RPOC. Medical management may include uterine contraction drugs and hemostatic agents, but invasive procedures like dilation and curettage (D&C) or hysteroscopic resection may be required.Imaging assessments, particularly through ultrasound (US), play a crucial role in the diagnosis and treatment planning of postpartum haemorrhage (PPH), except for uterine atony, where imaging techniques prove to be of limited utility in its management. Computed tomography play an important role in evaluation of trauma related PPH cases and MRI is essential in diagnosing and treatment planning of PAS and RPOC.Uterine artery embolization (UAE) has become a standard intervention for refractory PPH, offering a rapid, effective, and safe alternative to surgery with a success rate exceeding 85% (Rand T. et al. CVIR Endovasc 3:1-12, 2020). The technical approach involves non-selective uterine artery embolization with resorbable gelatine sponge (GS) in semi-liquid or torpedo presentation as the most extended embolic or calibrated microspheres. Selective embolization is warranted in cases with identifiable bleeding points or RPOC with AVM-like angiographic patterns and liquid embolics could be a good option in this scenario. UAE in PAS requires a tailored approach, considering the degree of placental invasion. A thorough understanding of female pelvis vascular anatomy and collateral pathways is essential for accurate and safe UAE.In conclusion, integrating interventional radiology techniques into clinical guidelines for primary and secondary PPH management and co-working during labour is crucial.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"17"},"PeriodicalIF":1.2,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10864234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selection of endovascular treatment strategies and analysis of the efficacy of different locations and types of splenic artery aneurysms. 选择血管内治疗策略,分析不同位置和类型的脾动脉瘤的疗效。
IF 1.2
CVIR Endovascular Pub Date : 2024-01-31 DOI: 10.1186/s42155-024-00427-9
Shenjie Wang, Wei Huang, Jingjing Liu, Qin Liu, Ziyin Wang, Qingbing Wang, Qungang Shan, Wenchang Li, Xiaoyi Ding, Zhiyuan Wu, Zhongmin Wang
{"title":"Selection of endovascular treatment strategies and analysis of the efficacy of different locations and types of splenic artery aneurysms.","authors":"Shenjie Wang, Wei Huang, Jingjing Liu, Qin Liu, Ziyin Wang, Qingbing Wang, Qungang Shan, Wenchang Li, Xiaoyi Ding, Zhiyuan Wu, Zhongmin Wang","doi":"10.1186/s42155-024-00427-9","DOIUrl":"10.1186/s42155-024-00427-9","url":null,"abstract":"<p><strong>Purpose: </strong>To analyze the selection of endovascular treatment strategies and the efficacy of various locations and types of splenic artery aneurysms (SAAs).</p><p><strong>Methods: </strong>Sixty-three cases of patients diagnosed with SAA from January 2016 to October 2021 were collected, and their clinical data and follow-up results were analyzed.</p><p><strong>Results: </strong>Among the 63 patients, 55 had true SAAs, and 8 had false SAAs. The average diameter of the true SAAs was 2.0 ± 0.8 cm. There were 10 cases of intra-aneurysm embolization, 24 cases of intra-aneurysm and aneurysm-bearing artery embolization, 10 cases of bare stent-assisted coil embolization, and 11 cases of stent grafts. The false SAAs had an average diameter of 2.3 ± 1.1 cm. Aneurysm-bearing artery embolization was applied in 5 cases, and stent grafts were applied in 3 cases. The incidence of complications after embolization of the aneurysm-bearing artery was higher (P < 0.01). Postembolization syndrome occurred in 10 patients; 7 patients developed splenic infarction to varying degrees, 1 patient had mildly elevated blood amylase, and 1 patient developed splenic necrosis with abscess formation, all of which improved after active treatment. The average length of hospital stay was 5.5 ± 3.2 days. The average follow-up time was 17.2 ± 16.1 months, and the aneurysm cavity of all patients was completely thrombotic.</p><p><strong>Conclusion: </strong>Endovascular treatments of SAAs are safe and effective. For various locations and types of SAAs, adequate selection of treatment is necessary. Stent grafts are recommended for their safety, economy, practicality, and preservation of the physiological functions of the human body.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"16"},"PeriodicalIF":1.2,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831027/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139643334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The RAVI registry: prospective, multicenter study of radial access in embolization procedures - 30 days follow up. RAVI 登记:栓塞手术中桡动脉入路的前瞻性多中心研究 - 30 天随访。
IF 1.2
CVIR Endovascular Pub Date : 2024-01-30 DOI: 10.1186/s42155-023-00415-5
Marcelo Guimaraes, Aaron Fischman, Hyeon Yu, Jordan Tasse, Jessica Stewart, Keith Pereira
{"title":"The RAVI registry: prospective, multicenter study of radial access in embolization procedures - 30 days follow up.","authors":"Marcelo Guimaraes, Aaron Fischman, Hyeon Yu, Jordan Tasse, Jessica Stewart, Keith Pereira","doi":"10.1186/s42155-023-00415-5","DOIUrl":"10.1186/s42155-023-00415-5","url":null,"abstract":"<p><strong>Background: </strong>There is a lack of registry studies about transradial access (TRA) outcomes. This prospective registry evaluated the TRA and procedure outcomes of visceral embolizations performed via TRA with 30-day follow-up.</p><p><strong>Material & methods: </strong>Prospective, multicenter registry included uterine fibroids (UFE), prostate artery (PAE), liver tumors (LT), and other hypervascular tumors (OHT) embolization performed in six US hospitals. Between February 2020 and January 2022, 99 patients underwent one radial artery visceral intervention (RAVI); 70 had UFE (70.7%), 16 PAE (16.2%), 7 LT (7.1%), and 6 OHT (6.1%). The mean age was 50.1 (±11.1) years, and 74/99 (74.7%) were females. The primary safety endpoints included hand ischemia, stroke, and death. Procedural success was defined as completing the intended procedure via radial artery (RA) access. Technical success was defined as the successful delivery of HydroPearl™ microspheres and complete embolization of the target vessel.</p><p><strong>Results: </strong>Procedural and technical successes were 100% and 97%, respectively. There was no stroke, hand ischemia, radial-to-femoral conversion, access-related serious adverse events, or clinically evident radial artery occlusion at 30 days. There were two deaths: one respiratory failure and one progression of liver disease. Minor RA-related adverse event included arterial spasm, hematoma, and post-procedure discomfort.</p><p><strong>Conclusion: </strong>This prospective, multicenter, open-label registry confirmed the high safety profile and effectiveness of radial access in UFE, PAE, LT, and OHT embolization procedures without stroke, hand ischemia, or access-related serious adverse events at 30-day follow-up.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"7 1","pages":"15"},"PeriodicalIF":1.2,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10828405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信